Cargando…

Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study

BACKGROUND: Familial hypercholesterolaemia (FH) leads to premature coronary artery diseases (CAD) which pathophysiologically can be measured by inflammation, endothelial activation and oxidative stress status. However, the status of these biomarkers among related unaffected relatives of FH cases and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahman, Thuhairah, Hamzan, Nur Suhana, Mokhsin, Atiqah, Rahmat, Radzi, Ibrahim, Zubin Othman, Razali, Rafezah, Thevarajah, Malathi, Nawawi, Hapizah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404314/ https://www.ncbi.nlm.nih.gov/pubmed/28438163 http://dx.doi.org/10.1186/s12944-017-0470-1

Ejemplares similares

Diagnostic performance of various familial hypercholesterolaemia diagnostic criteria compared to Dutch lipid clinic criteria in an Asian population
por: Abdul-Razak, Suraya, et al.
Publicado: (2017)

Familial Hypercholesterolaemia in the Malaysian Community: Prevalence, Under-Detection and Under-Treatment
por: Chua, Yung-An, et al.
Publicado: (2021)

Observational study of the status of coronary risk biomarkers among Negritos with metabolic syndrome in the east coast of Malaysia
por: Mokhsin, Atiqah, et al.
Publicado: (2018)

Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort
por: Nazli, Sukma Azureen, et al.
Publicado: (2022)

Heterozygous familial hypercholesterolaemia in a pair of identical twins: a case report and updated review
por: Mohd Nor, Noor Shafina, et al.
Publicado: (2019)

Low Serum High Density Lipoprotein Cholesterol Concentration is an Independent Predictor for Enhanced Inflammation and Endothelial Activation
por: Wan Ahmad, Wan Nor Hanis, et al.
Publicado: (2015)

Correction: Low Serum High Density Lipoprotein Cholesterol Concentration is an Independent Predictor for Enhanced Inflammation and Endothelial Activation
por: Wan Ahmad, Wan Nor Hanis, et al.
Publicado: (2015)

Genetic Spectrum of Familial Hypercholesterolaemia in the Malaysian Community: Identification of Pathogenic Gene Variants Using Targeted Next-Generation Sequencing
por: Razman, Aimi Zafira, et al.
Publicado: (2022)

Validity and reliability of an adapted questionnaire measuring knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia
por: Azraii, Ahmad Baihaqi, et al.
Publicado: (2021)

The genetics and screening of familial hypercholesterolaemia
por: Henderson, Raymond, et al.
Publicado: (2016)

Genetic Architecture of Familial Hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

Tendon xanthomas in familial hypercholesterolaemia
por: Bharath, Gopinath, et al.
Publicado: (2020)

Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK
por: Kerr, Marion, et al.
Publicado: (2017)

Cardiovascular risk stratification in familial hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2016)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Delta- and gamma-tocotrienol isomers are potent in inhibiting inflammation and endothelial activation in stimulated human endothelial cells
por: Muid, Suhaila, et al.
Publicado: (2016)

Atheroprotective effects of pure tocotrienol supplementation in the treatment of rabbits with experimentally induced early and established atherosclerosis
por: Rahman, Thuhairah Abdul, et al.
Publicado: (2016)

Familial hypercholesterolaemia: cholesterol efflux and coronary disease
por: Versmissen, Jorie, et al.
Publicado: (2016)

Management of homozygous familial hypercholesterolaemia in two brothers
por: Real, José, et al.
Publicado: (2018)

Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Dietary intervention for children and adolescents with familial hypercholesterolaemia
por: Capra, Maria Elena, et al.
Publicado: (2023)

Hippocampal Resting State Functional Connectivity in Patients With Schizophrenia and Unaffected Family Members
por: Edmiston, E. Kale, et al.
Publicado: (2020)

A perspective for sequencing familial hypercholesterolaemia in African Americans
por: Wright, Michelle L, et al.
Publicado: (2016)

The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data
por: Ramaswami, Uma, et al.
Publicado: (2017)

Dietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone
por: Diamond, David M, et al.
Publicado: (2021)

An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the “Ten Countries Study”
por: Pang, Jing, et al.
Publicado: (2017)

Comparable Enhanced Prothrombogenesis in Simple Central Obesity and Metabolic Syndrome
por: Mohd Nor, Noor Shafina, et al.
Publicado: (2018)

Attainment of Low-Density Lipoprotein Cholesterol Targets and Prescribing Pattern of Lipid-Lowering Medications among Patients with Familial Hypercholesterolemia Attending Specialist Clinics
por: Chua, Yung-An, et al.
Publicado: (2023)

LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives
por: Al-Allaf, Faisal A, et al.
Publicado: (2010)

Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia
por: Pears, Robert, et al.
Publicado: (2015)

Genetic diagnosis of familial hypercholesterolaemia by targeted next-generation sequencing
por: Maglio, C, et al.
Publicado: (2014)

Integration of child–parent screening and cascade testing for familial hypercholesterolaemia
por: Wald, David S, et al.
Publicado: (2018)

Cholesterol Levels in Genetically Determined Familial Hypercholesterolaemia in Russian Karelia
por: Korneva, V. A., et al.
Publicado: (2017)

Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care
por: Jones, Matthew, et al.
Publicado: (2022)

Improving detection and management of familial hypercholesterolaemia in Australian general practice
por: Brett, Tom, et al.
Publicado: (2021)

Case-finding and genetic testing for familial hypercholesterolaemia in primary care
por: Qureshi, Nadeem, et al.
Publicado: (2021)

Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia
por: Larrey, Dominique, et al.
Publicado: (2022)

How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?
por: Sarkies, Mitchell, et al.
Publicado: (2023)

Coronary artery calcium among patients with heterozygous familial hypercholesterolaemia
por: Tada, Hayato, et al.
Publicado: (2023)

Efficacy of statins in familial hypercholesterolaemia: a long term cohort study
por: Versmissen, Jorie, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_sqcjobafass2d82gid2erm53nn